Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Misty R Jenkins

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Elife|May 4, 2022
De novo-designed transmembrane domains tune engineered receptor functionsAssaf Elazar, Nicholas J Chandler, Ashleigh S Davey, et al.
Neuro-Oncology Advances|May 8, 2023
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine gliomaStacie S Wang, Alexander J Davenport, Melinda Iliopoulos, et al.
Blood Advances|January 4, 2018
PD-1 blockade enhances elotuzumab efficacy in mouse tumor modelsNatalie A Bezman, Amy Jhatakia, Alper Y Kearney, et al.
Frontiers in Oncology|August 28, 2023
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine gliomaKirti Pandey, Stacie S Wang, Nicole A Mifsud, et al.
Blood|February 5, 2013
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attackJamie A Lopez, Olivia Susanto, Misty R Jenkins, et al.
Cancer Research|March 3, 2017
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2<sup>+</sup> TumorsMikolaj Medon, Eva Vidacs, Stephin J Vervoort, et al.
Clinical & Translational Immunology|July 23, 2021
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Clinical & Translational Immunology|May 12, 2021
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Cell Death and Differentiation|March 25, 2022
BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cellsDiane Moujalled, Adam G Southon, Eiman Saleh, et al.
Diabetes|March 16, 2017
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD MicePrerak M Trivedi, Kate L Graham, Nicholas A Scott, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Elife|May 4, 2022
De novo-designed transmembrane domains tune engineered receptor functionsAssaf Elazar, Nicholas J Chandler, Ashleigh S Davey, et al.
Neuro-Oncology Advances|May 8, 2023
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine gliomaStacie S Wang, Alexander J Davenport, Melinda Iliopoulos, et al.
Blood Advances|January 4, 2018
PD-1 blockade enhances elotuzumab efficacy in mouse tumor modelsNatalie A Bezman, Amy Jhatakia, Alper Y Kearney, et al.
Frontiers in Oncology|August 28, 2023
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine gliomaKirti Pandey, Stacie S Wang, Nicole A Mifsud, et al.
Blood|February 5, 2013
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attackJamie A Lopez, Olivia Susanto, Misty R Jenkins, et al.
Cancer Research|March 3, 2017
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2<sup>+</sup> TumorsMikolaj Medon, Eva Vidacs, Stephin J Vervoort, et al.
Clinical & Translational Immunology|July 23, 2021
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Clinical & Translational Immunology|May 12, 2021
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Daniel J Verdon, Fiona M Gracey, et al.
Cell Death and Differentiation|March 25, 2022
BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cellsDiane Moujalled, Adam G Southon, Eiman Saleh, et al.
Diabetes|March 16, 2017
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD MicePrerak M Trivedi, Kate L Graham, Nicholas A Scott, et al.
Pageof 5